Cited by 33Diabetes Management and ResearchDiabetes Management and EducationOvarian function and disorders

Ambulatory Glucose Profile According to Different Phases of the Menstrual Cycle in Women Living With Type 1 Diabetes

Open access
Tatulashvili, Sopio, Baptiste Julla, Jean, Sritharan, Nanthara, Rezgani, Imen, Levy, Vincent, Bihan, Helene, Riveline, Jean-Pierre, Cosson, Emmanuel·2022·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: Some women living with type 1 diabetes complain of changes in glucose values according to the different phases of menstruation. Objective: To evaluate this variability through continuous glucose monitoring (CGM) data in type 1 diabetes patients. Design: Observational study. Setting: Ambulatory data, recruitment in 2 centers in the Paris region. Patients: Twenty-four women with type 1 diabetes having spontaneous menstrual cycles. Intervention: Collection of CGM data for 62 spontaneous menstrual cycles, with evaluation of five 3-day phases during each cycle: (1) early follicular (menstruations), (2) mid-follicular, (3) peri-ovulatory, (4) mid-luteal, and (5) late luteal. Main outcome measure: Time in range (TIR, prespecified). Results: TIR decreased for each consecutive phase (61 ± 18%; 59 ± 18%; 59 ± 20%; 57 ± 18%; and 55 ± 20%, P = 0.02). The linear mixed model highlighted a decrease in TIR in the mid-luteal (P = 0.03) and late luteal (P < 0.001) phases compared with the early follicular phase. Time above range was significantly higher during the late luteal phase than the early follicular phase (P = 0.003). Time below range was significantly higher during the mid-follicular phase than in the early follicular phase. Conclusion: In most of the study population, glucose levels rose linearly throughout the menstrual cycle, reaching a maximum in the late luteal phase. A sharp decrease was seen for most participants at the beginning of menstrual bleeding. This should be taken into consideration in daily care of type 1 diabetes patients to avoid hypoglycemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgac443

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fourteen studies were included in the systematic review.

    “We included 14 studies published between 1990 and 2022, with sample sizes from 4 to 124 patients.”

    From Menstrual Cycle, Glucose Control and Insulin Sensitivity in Type 1 Diabetes: A Systematic Review (2023) · cites this paper as [10]

    The Participants’ Characteristics section (page not provided) describes an original study of 24 women and 62 menstrual cycles, not a systematic review of 14 studies. The cited paper therefore does not support the attributed study count or the stated range of study sample sizes. (LLM, conf=0.88)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Brain insulin resistance could be involved in worse glycemic control in the luteal phase in women with type I diabetes.

    “This could also be involved in worse glycemic control in the luteal phase in women with type I diabetes40.”

    From Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase (2023) · cites this paper as [40]

    The Pathophysiology section says luteal-phase glycemic changes in women with type 1 diabetes may be linked to reduced insulin sensitivity, and the Conclusion reports worse time in range in the late luteal phase. The paper does not identify brain insulin resistance as the mechanism; that brain-specific part of the claim is unsupported. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • A number of variables and determinants (e.g., carbohydrate intake, physical activity, premenstrual syndrome symptoms, sleep quality and quantity) have to be considered when monitoring patients over a medium-to-long period.

    “the number of variables and determinants to be considered when monitoring patients over a medium-to-long period (i.e., carbohydrate intake, the frequency, duration and intensity of physical activity, premenstrual syndrome (PMS) symptoms and the quality and quantity of sleep) [8,9,10,11]”

    From Menstrual Cycle, Glucose Control and Insulin Sensitivity in Type 1 Diabetes: A Systematic Review (2023) · cites this paper as [10]

    The Outcomes section (page unavailable) says the study collected information on dietary changes, physical activity, and premenstrual syndrome symptoms during menstrual cycles. The Strengths and Limitations section (page unavailable) calls for more detailed study of food intake and physical activity. Our copy does not specify carbohydrate intake, the frequency, duration or intensity of activity, or sleep quality and quantity, nor does it make a general recommendation about medium-to-long-term monitoring. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Herranz L, Saez-de-Ibarra L, Hillman N, Gaspar R, Pallardo LF. Glycemic changes during menstrual cycles in women with type 1 diabetes. Med. Clin. (Barc.) 2016;146(7):287-291.

Cited by

Sorted by citations

Authors
Tatulashvili, S., Baptiste Julla, J., Sritharan, N., Rezgani, I., Levy, V., Bihan, H., Riveline, J.-P., & Cosson, E.
Affiliations
  • Inserm (FR)
  • AP-HP, Endocrinology and Diabetes Unit, Lariboisiere Hospital, University of Paris-Cité , 75010 Paris , France
  • Assistance Publique – Hôpitaux de Paris (FR)
  • AP-HP, Clinical Research Unit, Avicenne Hospital, SMBH Paris 13 , 93000 Bobigny , France
Corresponding author
Tatulashvili, Sopio
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2022-07-23
Volume
107
Issue
10
Pages
2793-2800
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4286669176
Cited by
33
References
21
Citations by year
2026: 11 · 2025: 10 · 2024: 6 · 2023: 6
FWCI
4.08
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Keywords
type 1 diabetes, menstrual cycle, continuous glucose monitoring, time in range, luteal phase, follicular phase, hypoglycemia, glycemic variability, women with diabetes
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 1, Female, Follicular Phase, Glucose, Humans, Luteal Phase, Menstrual Cycle, Blood Glucose Self-Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review